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tigaciones CCardiovascular disease, and the incidence of sudden cardiac death (SCD), will increase signiﬁcantly in
low- and middle-income countries (LMIC). Thus, SCD threatens to become a global public health
problem. We present a summary of the current research that has investigated the epidemiology of SCD
in LMIC. Few studies of SCD in LMIC exist, and they are of variable methodological quality. Risk factors for
SCD are described, taking into account recent global burden of disease and risk factor statistics. We
describe 1 proposal for a community-based, prospective, multiple-source methodology for SCD moni-
toring and surveillance that can be implemented in LMIC. Further research into the epidemiology of SCD
in LMIC, using standardized methodology, would allow investigators and policy makers to determine the
regions, communities, and individuals most at need for SCD prevention. Focusing on SCD and its
prevention in LMIC should be a priority for the global health community.Sudden cardiac death (SCD) is deﬁned as death
from an unexpected circulatory arrest, usually due
to a cardiac arrhythmia, occurring within an hour
of symptom onset [1]. Given the current and pro-
jected burden of cardiovascular disease (CVD) in
low- and middle-income countries (LMIC) [2,3],
it is likely that SCD will also increase in LMIC in
the future. Therefore, SCD threatens to become
a global public health problem, affecting populations
in LMIC as well as those in high-income countries
(HIC). Most reports of the epidemiology of SCD
have been conﬁned to HIC [4,5]. Unfortunately,
SCD data from LMIC are generally lacking, of vari-
able quality, and derived from different methodolo-
gies. This limits the applicability of a systematic
review of SCD epidemiology in LMIC and
precludes the possibility of performing a meta-
analysis. Instead, we present a summary of the
research that has investigated the epidemiology of
SCD in LMIC, highlighting the methodological
variation among the different studies, gaps in knowl-
edge, and future research opportunities. Further,
we describe a proposal for a community-based,ently employed by St. Jude Medical, Inc.
ena and Michael A. Wiener Cardiovascular Institute, Mount Sin
ardiovasculares, Madrid, Spain. Correspondence: R. Vedanthanprospective, multiple-source methodology for SCD
monitoring and surveillance that can be imple-
mented in LMIC.
E P I D EM IO LOGY OF S CD I N LM I C
Determining true occurrences of SCD is chal-
lenging. First, SCD occurs in the general popula-
tion in an unpredictable manner. Second, it is
critical to exclude subjects that are likely to have
died of a noncardiac cause. Third, even though
there is a universal deﬁnition of SCD, the practical
application of this deﬁnition is challenging, particu-
larly with respect to assignment of the appropriate
International Classiﬁcation of Diseases (ICD)-10
code on death certiﬁcates. Thus, death certiﬁcate
records may inaccurately record SCD as the cause
of death and retrospective analyses of death certiﬁ-
cates reﬂect that same inaccuracy [6,7]. An accurate
estimate of SCD incidence requires prospective
ascertainment of cases rather than retrospective
review of death certiﬁcates. Even in the United
States, the true incidence of SCD is unclear [5].ai School of Medicine, New York, NY, USA; Centro Nacional de Inves-
(rajesh.vedanthan@mssm.edu).
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354The ORE-SUDS (Oregon Sudden Unexpected
Death Study) used prospective surveillance
involving multiple sources of information, including
the emergency medical response system, the county
medical examiner’s ofﬁce, and emergency rooms of
local hospitals [8]. Cases were identiﬁed by physi-
cians from the emergency medical services or by
the county medical examiner; these potential cases
were then screened to determine which ones met
SCD criteria. The ORE-SUDS investigators
reported an annual SCD incidence of 53 per
100,000, using this methodology. Studies in other
HIC using similar methodology have reported
equivalent incidence rates for SCD, such as Ireland
(51 per 100,000) [9]. Using these incidence rates, it
has been estimated that the annual global incidence
of SCD would be approximately 4 to 5 million cases
[10]. However, this number may be inaccurate, as
the SCD incidence rates in LMIC may not be
equivalent to those in HIC.
A recent analysis from China used a prospective,
multiple-source surveillance methodology to ascer-
tain incident SCD events [11]. Three levels of case
reporting and ascertainment were used, and the
investigators worked intimately within the already
established administrative and bureaucratic structure
in China. This multilevel system of reporting and
ascertainment allowed for rigorous, prospective veri-
ﬁcation and conﬁrmation of SCD cases within the
community. The ﬁrst level of reporting included
the household administrative ofﬁce and health
station within neighborhoods. Case reporting at
this level involved examination of death certiﬁcates,
review of medical records, autopsy data, interviews
with family members, and review of data collected
by the household administrative ofﬁcer. The second
level consisted of data veriﬁcation and diagnosis
ascertainment at local hospitals and health centers
speciﬁc to each geographic region. The third level
involved ﬁnal case adjudication at the research coor-
dinating center. Using this multiple-source, multi-
level surveillance methodology, the China
investigators found an overall annual incidence of
41.8 per 100,000. The speciﬁc data sources used in
this study differed from ORE-SUDS due to differ-
ences in healthcare infrastructure and government
record-keeping practices between the United States
and China. However, the methodology as described
by the investigators appears to be quite robust.
The investigators also reported signiﬁcant variability
in SCD incidence rates by geographic region, with
age-standardized incidence rates higher in rural
provinces. Given the multiple levels of case reportingand ascertainment used in this study, it is unlikely
that these results reﬂect information bias.
Other studies fromLMIChave used diversemeth-
odologies of variable quality. An earlier study from
China, usingmultiple sources, but with a retrospective
methodology, reported SCD incidence rates between
7.3 and 29.5 per 100,000. A report from South Africa
investigated out-of-hospital cardiac arrest based only
on data from ﬁrst responders and yielded a SCD inci-
dence of 6.4 per 100,000 [13]. This value is likely an
underestimate, because a multiple-source method-
ology was not used. A recent study from southern
India used an innovative, but retrospective, method-
ology involving surveys of medical student respon-
dents and their relatives and found that SCD
contributed to 10.3% of recallable deaths [14]. The
data provided by the investigators, however, do not
allow for determination of SCD incidence.
These studies, despite the disparate methodolo-
gies and quality of study design, highlight that
SCD incidence rates are likely to differ signiﬁcantly
between HIC and LMIC, as well as between
different geographical regions [15] (Fig. 1). The
near totality of other studies of SCD in LMIC are
autopsy studies [16e23], hospital-based studies
[24,25], or are summary statistics of number of
implantable cardioverter-deﬁbrillators [26e28].
Such studies are unable to provide estimates of
SCD incidence in the community. Further research
into SCD epidemiology in LMICdusing a uniform,
robust, community-based, prospective, multiple-
source methodologydwould help to estimate the
true burden of SCD in LMIC.R I S K F A C TOR S FO R
S CDdI M P L I C A T I ON S O F G LOBA L
D I S E A S E BURD EN
SCD is the consequence of complex interaction
between upstream determinants, a variety of cardiac-
substrate conditions, and environmental triggers
(Fig. 2).
Upstream determinants: age and sex. Men have
a higher risk of SCD than women do, although
this difference decreases with age, likely due to the
increased risk of coronary artery disease (CAD)
among post-menopausal women [29]. Over time,
SCD prevalence has increased among women rela-
tive to men; whereas earlier studies had reported
a 1:3 ratio of women to men, more recent data
suggest that women now comprise approximately
40% of SCD cases in the United States [8].
Fig. 1. Sudden cardiac death (SCD) incidence rates (per
100,000) from different countries and regions, standardized to
the World Health Organization standard population [15]. US,
United States.
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355Average life expectancy is increasing in LMIC at
a more rapid pace than occurred in HIC in the 20th
century [30,31]. The disease burden of this increas-
ingly elderly population will consist of diseases such
as CAD and its complications, including SCD.
At the same time, CVD is affecting younger individ-
uals in LMIC; age-adjusted mortality from CVD is
greater in LMIC than in HIC [32]. SCD is a devas-
tating event, and it may threaten the economically
productive members of LMIC societies.
Upstream determinants: socioeconomic status. In
ORE-SUDS, the incidence of SCD was 30% to
80% higher among individuals living in neighbor-
hoods in the lowest socioeconomic quartile than it
was in those in the highest quartile [33], a pattern
similarly seen in other HIC settings [34,35]. Like-
wise, SCD incidence in China was found to be
higher in the rural, less-developed regions than it
was in urban, more-developed cities [11]. The cause
of this socioeconomic gradient of SCD burden is
not fully understood, but it may be related to
a higher burden of CAD risk factors combined with
poorer access to health care [29]. In many LMIC,
there is an inverse relationship between socioeco-
nomic status and burden of CVD and CVD risk
factors [32,36]. Thus, SCD may disproportionately
affect the poor in these regions.
Upstream determinants: cardiovascular risk
factors. CAD risk factors such as hypertension, dys-
lipidemia, tobacco, and diabetes mellitus (DM) all
contribute to SCD risk by increasing the risk ofCAD. In addition, DM has consistently been iden-
tiﬁed as a strong independent predictor of SCD
risk [37e39]. DM-speciﬁc accelerated forms of
atherosclerosis may exist with enhanced thrombo-
genicity [40]. Additionally, there is a high prevalence
of abnormal QT interval prolongation among dia-
betic individuals [41,42]. QT interval prolongation,
regardless of the primary cause, has been associated
with increased overall cardiac mortality [43].
Elevated blood glucose currently accounts for over
20% of ischemic heart disease deaths and over 15% of
stroke deaths worldwide [44], and the global burden
of DM is increasing rapidly, especially in LMIC
[45]. In China, the prevalence of DM increased
nearly 3-fold from 1980 to 1994, and current projec-
tions predict that this will continue to increase [46].
Similar trends have been reported in India [47] and
South Africa [48]. This trend foreshadows an even
greater and very concerning global burden of DM
and its associated complications, including SCD, in
the upcoming decades in LMIC.
Upstream determinants: genetic predisposition. The
association between genetics and SCD is clearly seen
in hereditary abnormalities in ion channel function
such as the long QT and Brugada syndromes [29].
Other associations are not as clear, but emerging data
have provided evidence that genetic factors may
contribute to the risk of SCD in patients without
an overt channelopathy [49,50]. In addition, even
monogenic syndromes, such as the long QT
syndrome, may involve modiﬁer genes and varying
degrees of penetrance [51]. Certain conditions are
more common in certain ethnic populations, such as
Brugada syndrome in Asians [52]. In addition, there
are an increasing number of genetic studies being
conducted inLMIC for various arrhythmic syndromes
that lead to SCD [53e55].
Substrate conditions: coronary artery
disease. Approximately 80% of SCD are attributed
to CAD [8,56,57]. The 2 major mechanisms of
fatal ventricular arrhythmias in patients with CAD
include: 1) acute coronary ischemia, usually as
a result of plaque rupture and occlusion of an
epicardial coronary artery; and 2) re-entry associated
with areas of slow conduction and previous
myocardial scarring [58]. In LMIC, the prevalence
of CAD is already substantial in nearly every
geographic region of the world [59]. It is expected
that the burden of CAD and CAD risk factors in
LMIC will increase signiﬁcantly over the next 2
decades [3,44]. Autopsy studies from several LMIC
already indicate that CAD accounts for a substantial
proportion of SCD cases [12,16,22]. SCD from
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Fig. 2. Schematic demonstrating the interaction among the risk factors for sudden cardiac death. CV, cardiovascular; DM, diabetes
mellitus; HTN, hypertension.
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356CAD in LMIC will inevitably increase in the future
as the burden of CAD rises.
Substrate conditions: left ventricular
dysfunction. Severe left ventricular dysfunction is the
most widely used predictor of SCD risk, independent
of the presence or absence of CAD. An autopsy
report from Nigeria concluded that the majority of
SCD cases were due to left ventricular failure
secondary to hypertensive heart disease [17]. In
Latin America, Chagas disease is a signiﬁcant risk
factor for SCD and is responsible for a substantial
proportion of SCD cases [60]. Congestive heart
failure as a result of CAD, rheumatic heart disease,
hypertensive heart disease, and inﬂammatory heart
disease is estimated to affect nearly 6 million people
per year worldwide [3]. The global human immu-
nodeﬁciency virus (HIV) epidemic is of particular
concern in this regard, as both HIV infection [61]
and antiretroviral medications [62] have been asso-
ciated with SCD. The dual and potentially over-
lapping epidemics of HIV and CVD in LMIC may
have profound implications for SCD in these
regions.Substrate conditions: cardiomyopathies and chan-
nelopathies. Cardiomyopathies (e.g., hypertrophic
cardiomyopathy, dilated cardiomyopathies, arrhyth-
mogenic right ventricular dysplasia, sarcoidosis, and
amyloidosis), congenital cardiac conditions (e.g.,
coronary anomalies, cyanotic/noncyanotic diseases),
and genetic channelopathies (e.g., long QT
syndromes, Brugada syndrome, and catecholamin-
ergic polymorphic ventricular tachycardia) account
for the remainder of SCD cases. As has already
been described, awareness is increasing about speciﬁc
cardiomyopathies and channelopathies in LMIC
that increase SCD risk [53e55].
Environmental triggers. A variety of environmental
triggers, in combination with the described substrate
conditions, has the potential to incite an episode
of unstable arrhythmia that can lead to SCD.
These triggers include activity (both vigorous
activity [63,64] and sleep [65]), stress [66], diet [67],
and pollution [68]. There remains a lack of consensus
regarding the relative importance of these different
triggers. In addition, the exact mechanisms by which
each trigger is related to the occurrence of SCD
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357remain unknown. However, some triggers, such as air
pollution, already contribute substantially to the global
burden of disease and are expected to increase
over time [44].
GLOBA L E P I D EM IO LOGY OF S CD :
A WAY FORWARD
To improve the understanding of SCD epidemi-
ology in LMIC, the global community should
consider developing and implementing more robust
monitoring and surveillance systems that are
prospective and multiple-source with reliable case
ascertainment. In the absence of widespread and
mature emergency medical response systems, alter-
native community-based strategies will be required.
One potential solution is to use community health
workers (CHW), who are community-based
workers who have received basic training to support
individuals and groups in their own communities to
access health and social services, to educate commu-
nity members about various health issues, and to
support overall community development [69e72].Fig. 3. Prospective, multiple-source methodology for sudden card
system.These individuals are able to conduct verbal autop-
sies of individuals who die in their respective juris-
dictions. A verbal autopsy is an interview carried
out with family members and/or caregivers of the
deceased using a structured questionnaire to elicit
signs and symptoms and other pertinent informa-
tion that can be used to assign a probable underlying
cause of death. Standardized protocols for verbal
autopsydincluding age group-speciﬁc question-
naires, cause-of-death certiﬁcation, ICD-10 coding,
and data management proceduresdhave been
developed by the World Health Organization
[73]. Whereas verbal autopsy is subject to several
limitationsdincluding reliability, accuracy, stan-
dardization, comparability, and validitydit has the
potential to improve the current situation of
extremely limited data with respect to SCD in
LMIC. Where possible, this information can be
supplemented by hospital or health center records
and medical response system data (Fig. 3).
Given the World Health Organization’s support
for integrating CHW into national health workforce
plans worldwide, this type of community-basediac death (SCD) surveillance. EMRS, emergency medical response
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be considered for implementation in LMIC.
However, given the important competing demands
and obligations for CHWdincluding infant and
child health, immunizations, nutrition, pre-natal
care, control of sexually transmitted diseases, and
general preventive care in adultsdit is quite possible
that CHW in LMIC will not have the time or
resources to monitor and document suspected cases
of SCD.
Therefore, we propose that this type of
community-based strategy for SCD monitoring
and surveillance be studied and evaluated in a few
sentinel surveillance and research settings in both
LMIC and HIC such as the United States. In addi-
tion to assessing the accuracy of verbal autopsy for
SCD diagnosis, it would be possible to ascertain
the costs associated with this type of surveillance,
spillover effects (both positive and negative) on
other duties of CHW, as well as impact on
mortality surveillance in general, which may have
important relevance for national vital statistics.
These data can then inform policy makers regarding
the usefulness and value of this proposal as
compared to alternatives.
CONC LU S I ON S
In light of the burden of CVD and CVD risk
factors in LMIC [3,44], it is likely that SCD will
become increasingly prevalent worldwide. However,there are currently insufﬁcient datadand those that
exist are of variable qualitydto arrive at robust
epidemiologic conclusions regarding the true
burden of SCD in LMIC and the regions, commu-
nities, and individuals most at need for SCD and
risk factor prevention. This will require continued,
focused investigations using standardized method-
ology. We recommend that SCD surveillance
systems, based on a prospective multiple-source
methodology, be studied and evaluated to determine
whether they would be appropriate, feasible, and
affordable in LMIC. The results of this research
will allow investigators and policy makers to deter-
mine whether to implement community-based
SCD surveillance on a widespread basis. In addi-
tion, in light of the complex interaction among
genetic predisposition, behavioral risk factors, bio-
logical substrates, and environmental triggers that
lead to SCD, ongoing investigation to identify
high-risk markers and predictors of SCD may ulti-
mately allow for development of risk scores that can
be tested in a wide spectrum of patient populations.
As we witness the epidemiologic transition world-
wide, focus on global SCD and its prevention
should be a priority for the global cardiovascular
community.
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